ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • March 16th, 2020 • Ideanomics, Inc. • Cable & other pay television services
This Additional Issuance Agreement (this “Agreement”), dated as of November 8, 2019, is made pursuant to Section 4.13 of that certain Securities Purchase Agreement, dated as of September 27, 2019 (the “Purchase Agreement”), as amended, by and between Ideanomics, Inc. (the “Company”) and ID Ventures 7, LLC (the “Purchaser”) for the purchase of the Company’s 10% Senior Secured Convertible Debentures due March 27, 2021 (the “Additional Debenture”), shares of Common Stock (“Additional Shares”) and Common Stock Purchase Warrants (“Additional Warrants” and together with the Additional Debentures and Additional Shares, the “Additional Securities”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • June 28th, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of June 27, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
EXHIBIT 99.5 ------------ ADDITIONAL ISSUANCE AGREEMENT This Additional Issuance Agreement (this "Agreement"), dated September 26, 2006, is made pursuant to that certain Securities Purchase Agreement, dated as of June 30, 2006 ("Purchase Agreement"),...Additional Issuance Agreement • October 2nd, 2006 • Arkados Group, Inc. • Services-business services, nec
FIFTH ADDITIONAL ISSUANCE AGREEMENT,Additional Issuance Agreement • May 11th, 2007 • Arkados Group, Inc. • Services-business services, nec
This Fifth Additional Issuance Agreement (this “Agreement”), dated February 28, 2007, is made pursuant to that certain Securities Purchase Agreement, dated as of June 30, 2006, as amended (the “Purchase Agreement”), by and between Arkados Group, Inc. (formerly CDKNET.COM, Inc., the “Company”), Bushido Capital Master Fund, LP (“Bushido”), Andreas Typaldos Family Limited Partnership (“Typaldos LP” and together with Bushido, the “New Purchasers”), Pierce Diversified Strategy Master Fund, LLC – Series BUS (“Pierce”) and Andreas Typaldos (“Typaldos”) for the purchase of the Company’s 6% Secured Convertible Debenture due December 28, 2008 (the “Debenture”) and the Common Stock purchase warrant issued in connection therewith (the “Warrant”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • October 23rd, 2020 • Defense Technologies International Corp. • Gold and silver ores
This Additional Issuance Agreement (this “Agreement”), dated as of October 16, 2020, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2018 (the “Purchase Agreement”), as amended, by and between Defense Technologies International Corp. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Original Issue Discount Convertible Debentures (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • November 8th, 2018 • GeoVax Labs, Inc. • Services-commercial physical & biological research
This Additional Issuance Agreement (this “Agreement”), dated as of September 5, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of March 5, 2018 (the “Purchase Agreement”), as amended, by and between GeoVax Labs, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Series E Convertible Preferred Stock (the “Additional Preferred Stock”) and Common Stock Purchase Warrants (“Warrants”, and together with the Additional Preferred Stock, the “Additional Securities”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • September 16th, 2016 • Propanc Health Group Corp • Pharmaceutical preparations
This Additional Issuance Agreement (this “Agreement”), dated as of September 13, 2016, is made pursuant to that certain Securities Purchase Agreement, dated as of October 28, 2015, as amended on March 11, 2016 by addendum and by letter agreement on July 1, 2016, and by letter agreement on August 3, 2016 (the “Purchase Agreement”), by and between Propanc Health Group Corporation, a Delaware corporation (the “Company”), and Delafield Investments Limited for the purchase of the Company’s 5% Original Issue Discount Senior Secured Convertible Debenture due February 28, 2017 (the “Debenture”) and the Common Stock purchase warrants issued and outstanding in connection therewith (collectively, the “Warrants”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • December 28th, 2018 • GeoVax Labs, Inc. • Services-commercial physical & biological research
This Additional Issuance Agreement (this “Agreement”), dated as of December 27, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of March 5, 2018 (the “Purchase Agreement”), as amended, by and between GeoVax Labs, Inc. (the “Company”) and the purchasers signatory hereto (the “Purchaser”) for the purchase of the promissory notes (the “Promissory Notes”) and Common Stock Purchase Warrants (“New Warrants”, and together with the Promissory Notes, the “Additional Securities”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • March 16th, 2020 • Ideanomics, Inc. • Cable & other pay television services
This Additional Issuance Agreement (this “Agreement ”), dated as of December 19, 2019, is made in satisfaction of the conditions required under the Consent (“Consent”), dated as of the date hereof, being given under the Company’s 10% Senior Secured Convertible Debentures due March 27, 2021 and Common Stock Purchase Warrants ( “Warrants”) issued pursuant to that certain Securities Purchase Agreement, dated as of September 27, 2019 (the “Purchase Agreement”), as amended, by and between Ideanomics, Inc. (the ''Company'') and ID Venturas 7, LLC (the “Purchaser”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • July 16th, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of July 16, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • December 20th, 2006 • Unity Wireless Corp • Radiotelephone communications
This Additional Issuance Agreement (“Amendment”), dated ___________, 2006, is made pursuant to that certain Securities Purchase Agreement, dated as of February 27, 2006 (“Purchase Agreement”), by and between Unity Wireless Corporation (the “Company”) and ________________ (a “New Purchaser”) for the purchase of the Company’s 8% Senior Secured Convertible Debenture due February 28, 2009 (the “Debenture”) and the Common Stock Purchase Warrants issued in connection therewith (the “Warrant”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • February 23rd, 2017 • Soupman, Inc. • Retail-nonstore retailers
This Additional Issuance Agreement (this “Agreement”), dated as of February 21, 2017, is made pursuant to that certain Securities Purchase Agreement, dated as of July 26, 2016 (the “Purchase Agreement”), as amended, by and between Soupman, Inc., (the “Company”) and Hillair Capital Investments L.P. (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture Due April 21, 2017 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • April 28th, 2017 • EnerJex Resources, Inc. • Crude petroleum & natural gas
This Additional Issuance Agreement (this “Agreement”), dated as of April __, 2017, is made pursuant to that certain Securities Purchase Agreement, dated as of March 11, 2015, as amended (the “Purchase Agreement”), by and between EnerJex Resources, Inc. (the “Company”) and Alpha Capital Anstalt (the “Purchaser”) for the purchase of the Company’s Series C Convertible Preferred Stock (the “Preferred Stock”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
